Anavex Life Sciences (AVXL) Reports Data from Review by Independent DSMB for U.S. Phase 2 Clinical Trial of ANAVEX2-73
Tweet Send to a Friend
Anavex Life Sciences Corp. (NASDAQ: AVXL) today announced that the Independent Data Safety Monitoring Board (DSMB) for the Company's U.S ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
